Induction of neutralizing antibodies against dengue virus type 2 upon mucosal administration of a recombinant Lactococcus lactis strain expressing envelope domain III antigen.
about
Development of Neutralization Assay Using an eGFP Chikungunya VirusA non mouse-adapted dengue virus strain as a new model of severe dengue infection in AG129 miceImmune response to Lactobacillus plantarum expressing Borrelia burgdorferi OspA is modulated by the lipid modification of the antigenLactococci and lactobacilli as mucosal delivery vectors for therapeutic proteins and DNA vaccines.Selection and Characterization of DNA Aptamers Targeting All Four Serotypes of Dengue VirusesMucosal and systemic immune responses induced by recombinant Lactobacillus spp. expressing the hemagglutinin of the avian influenza virus H5N1.Responses of primary human nasal epithelial cells to EDIII-DENV stimulation: the first step to intranasal dengue vaccination.Domain III of the envelope protein as a dengue vaccine target.Development of vaccine delivery vehicles based on lactic acid bacteria.Oral immunization with recombinant Lactococcus lactis expressing the hemagglutinin of the avian influenza virus induces mucosal and systemic immune responses.Eliciting cross-neutralizing antibodies in mice challenged with a dengue virus envelope domain III expressed in Escherichia coli.Oral immunization of a non-recombinant Lactococcus lactis surface displaying influenza hemagglutinin 1 (HA1) induces mucosal immunity in mice.
P2860
Q26314416-7479B9BA-9EE4-4F06-AFB7-F74641D2628BQ28473775-7888A985-349F-4EDC-A167-4AB177132A63Q28751429-33F38869-706E-49E4-94A1-A240C13FF503Q35596025-A1731DEB-9B84-4782-9B12-992CC4D63747Q35674292-105535A5-F1C2-4781-A409-EABCEC59DFF0Q35739107-F1AAA090-119D-4748-AB28-1FA791DC8E9EQ37189330-57DC67D6-64A3-4BC1-B3AA-D960FE4C1667Q37682895-323543E4-EADF-472D-9468-834E9725B367Q37928954-84AC1734-6585-4686-9F93-3CA50CA22194Q39565371-93BEABF8-BC65-4014-97CA-119897B32BB7Q40293191-BBDD4A8A-E452-4C5F-AE14-B8966CD1D3D0Q45391504-05B989CD-90C1-4820-834B-B5ABA90DE873
P2860
Induction of neutralizing antibodies against dengue virus type 2 upon mucosal administration of a recombinant Lactococcus lactis strain expressing envelope domain III antigen.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Induction of neutralizing anti ...... g envelope domain III antigen.
@en
type
label
Induction of neutralizing anti ...... g envelope domain III antigen.
@en
prefLabel
Induction of neutralizing anti ...... g envelope domain III antigen.
@en
P2093
P1433
P1476
Induction of neutralizing anti ...... g envelope domain III antigen.
@en
P2093
Adrian C N Sim
Grace K X Tan
Magenta S T Sim
Sylvie Alonso
Vincent T K Chow
Wenwei Lin
P304
P356
10.1016/J.VACCINE.2007.12.047
P407
P577
2008-01-18T00:00:00Z